We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » J&J to Challenge $8 Billion Risperdal Award As ‘Excessive and Unfounded’
J&J to Challenge $8 Billion Risperdal Award As ‘Excessive and Unfounded’
Johnson & Johnson said it will contest a Philadelphia jury’s decision to award $8 billion to a man who claimed its drug Risperdal (risperidone) caused him to grow breasts.